Several mechanisms are known to contribute to the pathology of menopause-induced primary osteoporosis such as increased expression of tumour necrosis factor (TNF) superfamily members TNFα (TNFSF2) and receptor activator of nuclear factor kappa-B ligand (RANKL; TNFSF11) [6–11]. This evidence concerns the gene TNFSF11 and osteoporosis.